Pretomanid: The latest USFDA-approved anti-tuberculosis drug-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pretomanid: The latest USFDA-approved anti-tuberculosis drug

Published:2021-04 Issue:2 Volume:68 Page:287-291
ISSN:0019-5707
Container-title:Indian Journal of Tuberculosis
language:en
Short-container-title:Indian Journal of Tuberculosis

Author:

Deb Uttiya^ORCID,Biswas Supreeti

Funder

USFDA

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference31 articles.

1. Global Tuberculosis Report 2019,2019

2. TB Drug Resistance Types,2019

3. The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis,2013

4. The Use of Delaminid in the Treatment of Multidrug-Resistant Tuberculosis,2014

5. FDA Approves New Drug for Treatment-Resistant Forms of Tuberculosis that Affects the Lungs [Internet],2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion;Drug Delivery and Translational Research;2024-06-05

2. Third Generation Solid Dispersion-Based Formulation of Novel Anti-Tubercular Agent Exhibited Improvement in Solubility, Dissolution and Biological Activity;The AAPS Journal;2024-04-22

3. Tuberculosis;Pediatric Pulmonology;2023-11-17

4. Analog-based Design and Development of Novel Molecules as Anti-tubercular Agents;Indian Journal of Pharmaceutical Education and Research;2023-03-14

5. Pretomanid development and its clinical roles in treating tuberculosis;Journal of Global Antimicrobial Resistance;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP